RT Journal Article
SR Electronic
T1 Progesterone/Estradiol Ratio Is Related to Real-Life Alcohol Consumption in Alcohol Use Disorder in a Sex- and Menstrual Cycle Phase-Dependent Manner
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.12.21.22282762
DO 10.1101/2022.12.21.22282762
A1 Hoffmann, Sabine
A1 Gerhardt, Sarah
A1 Mühle, Christiane
A1 Reinhard, Iris
A1 Reichert, Dominic
A1 Bach, Patrick
A1 Boroumand-Jazi, Rafat
A1 Kuehner, Christine
A1 Aguilera, Alvaro
A1 Aslan, Acelya
A1 Bahr, Nadja S.
A1 Belanger, Matthew
A1 Deeken, Friederike
A1 Ebrahimi, Claudia
A1 Fischbach, Pascale C.
A1 Ganz, Marvin
A1 Garbusow, Maria
A1 Großkopf, Charlotte M.
A1 Heigert, Marie
A1 Hentschel, Angela
A1 Karl, Damian
A1 Liu, Shuyan
A1 Mazza, Massimiliano
A1 Pelz, Patricia
A1 Pinger, Mathieu
A1 Reichl, Matthias
A1 Riemerschmid, Carlotta
A1 Rosenthal, Annika
A1 Steffen, Johannes
A1 Strehle, Jens
A1 Wedemeyer, Friederike
A1 Weiss, Franziska
A1 Wenzel, Julia
A1 Wieder, Gesine
A1 Wieland, Alfred
A1 Zaiser, Judith
A1 Zech, Hilmar
A1 Zimmermann, Sina
A1 Kornhuber, Johannes
A1 Müller, Christian P.
A1 Sommer, Wolfgang H.
A1 Spanagel, Rainer
A1 Banaschewski, Tobias
A1 Deserno, Lorenz
A1 Ebner-Priemer, Ulrich W.
A1 Flor, Herta
A1 Kirsch, Peter
A1 Rietschel, Marcella
A1 Vollstädt-Klein, Sabine
A1 Walter, Henrik
A1 Meyer-Lindenberg, Andreas
A1 Rapp, Michael A.
A1 Witt, Stephanie
A1 Smolka, Michael N.
A1 Heinz, Andreas
A1 Tost, Heike
A1 Kiefer, Falk
A1 Reichert, Markus
A1 Lenz, Bernd
A1 the ReCoDe-Consortium
YR 2022
UL http://medrxiv.org/content/early/2022/12/22/2022.12.21.22282762.abstract
AB Background Alcohol use disorder (AUD) is a critical public health issue with sex-specific characteristics and the need for a better mechanistic understanding. Initial evidence suggests that progesterone can reduce alcohol intake, while estradiol leads to an increase. However, we lack knowledge about how progesterone relative to estradiol influences alcohol use patterns in females and males with AUD.Methods This multicenter within-subject study analyzed data on real-life alcohol use (21,438 intensively-sampled smartphone entries), menstrual cycle, and serum progesterone/estradiol ratios (677 blood samples) gathered during a 12-month follow-up in 74 naturally cycling females and 285 males with AUD (mean age: 29.7 and 37.8 years, respectively; data collection: 2020–2022). We used multilevel modelling to identify changes in alcohol use and progesterone/estradiol ratios across the menstrual cycle in females and associations between progesterone/estradiol ratios and alcohol use in males.Results During the late luteal phase, females showed 0.6- to 0.8-fold lower (predicted) probabilities of binge drinking and 2.8- to 5.6-fold higher mean progesterone/estradiol ratios compared to the menstrual, follicular, and ovulatory phases. Similarly, in males, an increase of 10 units in the progesterone/estradiol ratio was related to 8 and 9% lower probabilities of binge drinking and any alcohol use, respectively.Conclusions Based on ecologically valid results, this study reveals that higher progesterone/estradiol ratios can protect against problematic alcohol use in females and males with AUD. Therefore, the progesterone/estradiol ratio is a promising treatment target. Translated into clinical practice, our results also indicate that females with AUD may benefit from menstrual cycle phase-tailored treatments.Competing Interest StatementUlrich W. Ebner-Priemer is a consultant for Boehringer Ingelheim.Funding StatementThe project was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project-ID 402170461 - TRR265 (38). C.M. is a member of the research training group 2162 'Neurodevelopment and Vulnerability of the Central Nervous System' of the DFG (GRK2162 / 270949263). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project was approved by the local ethics committees of Charite - Universitaetsmedizin Berlin, Technical University Dresden, and Heidelberg University.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors